SAMLYN CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Inozyme Pharma, Inc. (INZY)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
Samlyn Capital, LLC
Security
Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share
Symbol
INZY
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 01:59 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samlyn Capital, LLC 0% 0 0 0 By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Samlyn, LP 0% 0 0 0 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly/Managing Member*
Robert Pohly 0% 0 0 0 /s/ Robert Pohly Robert Pohly*